Stockreport

Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing

Harrow, Inc.  (HROW) 
Last harrow, inc. earnings: 11/13 04:21 pm Check Earnings Report
PDF MELT-300 Pivotal Phase 3 Program Topline Readout Expected in Q4 2024 NASHVILLE, Tenn.--(BUSINESS WIRE)--Melt Pharmaceuticals, Inc. (“Melt”), a clinical-stage pharmace [Read more]